These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15321995)

  • 1. Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.
    Staalsoe T; Shulman CE; Dorman EK; Kawuondo K; Marsh K; Hviid L
    Infect Immun; 2004 Sep; 72(9):5027-30. PubMed ID: 15321995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment.
    Aitken EH; Mbewe B; Luntamo M; Maleta K; Kulmala T; Friso MJ; Fowkes FJ; Beeson JG; Ashorn P; Rogerson SJ
    J Infect Dis; 2010 May; 201(9):1316-25. PubMed ID: 20350189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.
    Serra-Casas E; Menéndez C; Bardají A; Quintó L; Dobaño C; Sigauque B; Jiménez A; Mandomando I; Chauhan VS; Chitnis CE; Alonso PL; Mayor A
    J Infect Dis; 2010 Jan; 201(1):123-31. PubMed ID: 19954383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
    Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
    Am J Trop Med Hyg; 2006 Jun; 74(6):960-4. PubMed ID: 16760504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamine.
    Quelhas D; Jiménez A; Quintó L; Serra-Casas E; Mayor A; Cisteró P; Puyol L; Wilson DW; Richards JS; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Aponte JJ; Alonso PL; Beeson JG; Menéndez C; Dobaño C
    Immunobiology; 2011 Jul; 216(7):793-802. PubMed ID: 21257227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of intermittent presumptive treatment with sulfadoxine-pyrimethamine on the acquisition of anti-VAR2CSA antibodies in pregnant women living in a hypoendemic area in Senegal].
    Diouf I; Tine RC; Ndiaye JL; Sylla K; Faye B; Mengue ML; Faye O; Dieng Y; Gaye A; Gaye O
    Bull Soc Pathol Exot; 2011 Oct; 104(4):277-83. PubMed ID: 21818679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
    Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
    Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
    J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.
    Staalsoe T; Shulman CE; Bulmer JN; Kawuondo K; Marsh K; Hviid L
    Lancet; 2004 Jan; 363(9405):283-9. PubMed ID: 14751701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia.
    Staalsoe T; Megnekou R; Fievét N; Ricke CH; Zornig HD; Leke R; Taylor DW; Deloron P; Hviid L
    J Infect Dis; 2001 Sep; 184(5):618-26. PubMed ID: 11494167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy.
    Nyunt MM; Adam I; Kayentao K; van Dijk J; Thuma P; Mauff K; Little F; Cassam Y; Guirou E; Traore B; Doumbo O; Sullivan D; Smith P; Barnes KI
    Clin Pharmacol Ther; 2010 Feb; 87(2):226-34. PubMed ID: 19776738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.
    Mbonye AK; Schultz Hansen K; Bygbjerg IC; Magnussen P
    Public Health; 2008 May; 122(5):516-25. PubMed ID: 18358506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug?
    Parikh S; Rosenthal PJ
    Clin Pharmacol Ther; 2010 Feb; 87(2):160-2. PubMed ID: 20107451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
    J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
    Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent preventive treatment against malaria: an update.
    Gosling RD; Cairns ME; Chico RM; Chandramohan D
    Expert Rev Anti Infect Ther; 2010 May; 8(5):589-606. PubMed ID: 20455687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
    Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
    Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.
    Keen J; Serghides L; Ayi K; Patel SN; Ayisi J; van Eijk A; Steketee R; Udhayakumar V; Kain KC
    PLoS Med; 2007 May; 4(5):e181. PubMed ID: 17535103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates.
    Khattab A; Reinhardt C; Staalsoe T; Fievet N; Kremsner PG; Deloron P; Hviid L; Klinkert MQ
    Malar J; 2004 Jul; 3():21. PubMed ID: 15242514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.